Table: OK Biotech Apr Rev NT$127.2M Vs NT$140.4M

About this update from Ok Biotech Co., Ltd.

OK Biotech Co. Ltd. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$127,200,000 NT$140,381,000 Jan-Apr Revenue NT$510,844,000 NT$553,861,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to [email protected].

View stock analysis, news, and events for Ok Biotech Co., Ltd.